| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/08/2004 | EP1285003B1 Use of a secondary cell wall polymer of procaryotic microorganisms |
| 09/08/2004 | EP1208220B1 Culture medium using ballasted ph indicators |
| 09/08/2004 | EP1017802B1 A potential effector for the grb7 family of signalling proteins |
| 09/08/2004 | EP0994183B1 Functional compositions |
| 09/08/2004 | EP0870042B1 Improved methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods |
| 09/08/2004 | CN1527882A Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 09/08/2004 | CN1527880A Enhanced 2-keto-L-gulonic acid production |
| 09/08/2004 | CN1527879A Nucleic acid and protein sequences of bovine epidermal growth factor |
| 09/08/2004 | CN1527878A Shingolipid ceramide deacylase gene |
| 09/08/2004 | CN1527720A Global analysis of protein activities using proteome chips |
| 09/08/2004 | CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 09/08/2004 | CN1526821A New glucoamylase and coding its nucleic acid sequence |
| 09/08/2004 | CN1526820A Promotor for expressing gene in fungal cell |
| 09/08/2004 | CN1526815A Common phytase |
| 09/08/2004 | CN1526813A Prepn process and application of amylolytic bacillus CH-2 strain |
| 09/08/2004 | CN1526732A Process for producing high pureness albumin solution |
| 09/08/2004 | CN1165621C Farnesyl diphosphate synthase |
| 09/08/2004 | CN1165620C Mutant prenyl diphosphate synthase |
| 09/08/2004 | CN1165619C Process for producing L-lysine |
| 09/08/2004 | CN1165615C Subtilase variants and compositions |
| 09/08/2004 | CN1165613C Protein for inhancing tolerance of colibacillus to L-amino acid, coding gene and use thereof |
| 09/08/2004 | CN1165612C One brewer's yeast engineering saccharomycete strain and the production process of alcohol and ergosterin with the strain |
| 09/08/2004 | CN1165611C Green muscardine and use thereof |
| 09/08/2004 | CN1165610C Aspergillus niger and its microbial conversion process of producing vanillic acid and vanillic aldehyde |
| 09/07/2004 | US6787644 Metalloprotease-disintegrin ADAM23 (SVPH3-17) nucleic acids |
| 09/07/2004 | US6787643 Nucleic acid for use in kits for detection of preferential bacterial infection |
| 09/07/2004 | US6787641 Identification of sel-12 and uses thereof |
| 09/07/2004 | US6787360 Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof |
| 09/07/2004 | US6787352 Nucleotide sequences coding polypeptide fpr use in the human therapeutics, pharmacology, foods and animal feeds |
| 09/07/2004 | US6787348 Useful in the manufacturing of food and feed products; includes lactic acid bacteria (lactococcus) |
| 09/07/2004 | US6787347 Microorganisms for use in the generation of preferential cyclopentene |
| 09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
| 09/07/2004 | US6787340 Liquid phase fermentation; forming xanthan gum from glucose, dextrose |
| 09/07/2004 | US6787336 DNA encoding growth hormone antagonists |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/07/2004 | US6787328 Methods and compositions relating to CD39-like polypeptides and nucleic acids |
| 09/07/2004 | US6787327 Encoded by isolated nucleic acid; high throughput enzymatic assay; screening for modulators of enzymatic activity |
| 09/07/2004 | US6787316 DNA cloning method |
| 09/07/2004 | US6787307 Lysate clearance and nucleic acid isolation using silanized silica matrices |
| 09/07/2004 | US6787146 Vaccines against neosporosis useful in the prevention of clinical disease and abortion in mammals. |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/06/2004 | CA2457423A1 Method for fermentative preparation of s-adenosylmethionine |
| 09/02/2004 | WO2004074496A1 Food product and process for their preparation by enzymatic galactosyltransfer with lactobacillus alpha-galactosidase |
| 09/02/2004 | WO2004074495A1 Highly efficient hydrogen production method using microorganism |
| 09/02/2004 | WO2004074487A1 Microbial production of coq10 |
| 09/02/2004 | WO2004074476A1 Novel vector |
| 09/02/2004 | WO2004074469A1 Polypeptides comprising sequences characteristic of pyrrolidone carboxylic peptidases, polynucleotides comprising a sequence coding for said polypeptides, and use thereof particularly for diagnostic purposes |
| 09/02/2004 | WO2004074461A2 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | WO2004074458A2 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 09/02/2004 | WO2004074456A2 Methods for selecting medications |
| 09/02/2004 | WO2004074445A2 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/02/2004 | WO2004074437A2 Compositions and methods for cancer immunotherapy |
| 09/02/2004 | WO2004074318A2 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
| 09/02/2004 | WO2004073604A2 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity |
| 09/02/2004 | WO2004073603A2 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity |
| 09/02/2004 | WO2004073418A1 Control of enzymatic degradation of glucosinolates by lactic acid bacterium |
| 09/02/2004 | WO2004040955B1 Microbiological method for producing ascorbic acid |
| 09/02/2004 | WO2004024084A3 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 09/02/2004 | WO2003072813A3 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy |
| 09/02/2004 | WO2003004689A3 Regulators of biofilm formation and uses thereof |
| 09/02/2004 | US20040172687 Modified proteinase inhibitors |
| 09/02/2004 | US20040172675 using a D-specific enoyl-CoA hydratase gene in genetically engineered klebsiella, aeromonas, clostridium, and escherichia |
| 09/02/2004 | US20040172670 Maize yellow stripe1 and related genes |
| 09/02/2004 | US20040171811 for drug screening using animal models with in vitro activation; genetic engineering |
| 09/02/2004 | US20040171810 used to find a novel protein linked to the cytomatrix and considered to play an important role in synaptogenesis |
| 09/02/2004 | US20040171807 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 09/02/2004 | US20040171806 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171803 Artificial protein having potentiated immunogenicity of epitope |
| 09/02/2004 | US20040171802 Haemophilus influenzae antigens and corresponding dna fragments |
| 09/02/2004 | US20040171801 Nk-2 homeobox transcription factor |
| 09/02/2004 | US20040171569 that directs formation of a recombinant virus upon introduction into a cell |
| 09/02/2004 | US20040171565 vaccines that express derivatives of ADP-ribosyltransferase toxins that display significantly reduced, or are deficient in, intrinsic ADP-ribosyltransferase activity (i.e. herein referred to as mARTs) and yet retain adjuvanticity |
| 09/02/2004 | US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment |
| 09/02/2004 | US20040171538 Anticoagulants and their uses |
| 09/02/2004 | US20040171517 Compounds and methods for modulating bacterial functions |
| 09/02/2004 | US20040171160 Method for producing a marker-free mutated target organism and plasmid vectors suitable for the same |
| 09/02/2004 | US20040171157 Recombinational cloning using nucleic acids having recombination sites |
| 09/02/2004 | US20040171156 for moving or exchanging segments of DNA molecules using proteins to provide chimeric DNA molecules in vitro and in vivo |
| 09/02/2004 | US20040171134 Method for producing recombinant of methanol-assimilating bacterium |
| 09/02/2004 | US20040171130 Comprises polypeptide associated with pentose phosphate pathway for use in preparation of amino acids for use in cosmetics, foods and pharmeceuticals |
| 09/02/2004 | US20040171128 Generating heteropolysaccharides for use as drug delivery agents, antimicrobial agents, emulsifiers, emulsion stabilizers, biosurfactants, imaging probes, diagnostic tools and contrast agents |
| 09/02/2004 | US20040171125 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171121 Methods for preparing Bacillus anthracis sporulation deficient mutants and for producing recombinant Bacillus anthracis protective antigen for use in vaccines |
| 09/02/2004 | US20040171120 Enhanced insecticidal protein for killing bettles, moths, flies; biolgical pest control |
| 09/02/2004 | US20040171119 Reductase gene and use of the same |
| 09/02/2004 | US20040171117 Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disorders |
| 09/02/2004 | US20040171113 Antigens of group b streptococcus and corresponding dna fragments |
| 09/02/2004 | US20040171110 Novel member of the lysyl oxidase gene family |
| 09/02/2004 | US20040171107 Modified flourescent proteins |
| 09/02/2004 | US20040171106 Process for producing dipeptides |
| 09/02/2004 | US20040171104 may be used in food related applications to improve flavor, such as baking; genetic engineering |
| 09/02/2004 | US20040171067 Identifying modulators of g protein coupled receptor activity for diagnosing, treating and preventing disorders associated with cholesterol metabolism, cancer, infections and inflammation |
| 09/02/2004 | US20040171042 Functional assays that use theT1R1 receptor to screen for T1R1-associated taste modulators |
| 09/02/2004 | US20040171041 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences |
| 09/02/2004 | US20040171023 Utilization of starch for biological production by fermentation |
| 09/02/2004 | US20040171020 Glanders/meliodosis vaccines |
| 09/02/2004 | US20040171018 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 09/02/2004 | US20040171015 Cyp450-specific dna probes and primers, and biological applications thereof |